pharma · Polycythemia Vera · Ulcerative Colitis Chronic Moderate · PTGX
Protagonist Therapeutics
Protagonist Therapeutics, Inc
Protagonist Therapeutics clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
7707 Gateway Blvd, Suite 140, Newark, California 94560, US HQ
2006 Founded
153 Employees
Public company Type
PTGX · NYSE Ticker
Company details
- Status
- Public
- HQ
- 7707 Gateway Blvd, Suite 140, Newark, California 94560, US
- Founded
- 2006
- Employees
- 153
- Programs
- 13
- Drugs
- 5
- Patents
- 33
Protagonist Therapeutics projects
0 ClinicalTrials.gov programs sponsored by Protagonist Therapeutics.
Protagonist Therapeutics has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
No programs matched
Frequently asked questions
How many clinical projects does Protagonist Therapeutics have?
0 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.